The study examined AI’s potential to enable would-be bioterrorists that would otherwise lack the skill and confidence to plan ...

A strand of Merz Pharmaceuticals’ star-studded promotion of the anti-wrinkle drug Xeomin has landed it a reprimand from the ...

Barclays analyst Balaji Prasad maintained a Hold rating on Revance Therapeutics (RVNC – Research Report) today and set a price target of $7.00.

Jean Carruthers, an ophthalmologist, came home from work one evening and told her dermatologist husband Alastair about a conversation she had had with a patient. As part of a clinical trial1 she was ...

A series of botulism cases in Italy and France have raised concerns about food safety. What can people do to avoid the deadly ...

But the mouth stuff was unexpected. Some were grinding their teeth at night and needed mouthguards. Others had doctors inject ...

For those with lupus, Botox has a heightened risk of side effects. It can also interact with your lupus medications, so it's ...

Dermata nears completion of enrollment in its DMT310 Phase 3 Spongilla Treatment of Acne Research (STAR-1) clinical trial - - ...

NEW YORK, Nov. 12, 2024 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, The botulinum toxin market is expected to reach a value of US$ 19.03 billion by 2031 from US$ ...